» Authors » Michael Eldar

Michael Eldar

Explore the profile of Michael Eldar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 1422
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sabbag A, Morag Y, Beinart R, Bogdan S, Kuperstein R, Feinberg M, et al.
J Interv Card Electrophysiol . 2019 Jul; 58(1):87-94. PMID: 31332607
Purpose: Response to cardiac resynchronization therapy (CRT) is well-established in patients with typical left bundle branch block (LBBB) but modest or even negative in those with intraventricular conduction delay (IVCD)....
2.
Ram E, Sternik L, Klempfner R, Eldar M, Goldenberg I, Peled Y, et al.
J Cardiothorac Vasc Anesth . 2019 Jan; 33(6):1648-1656. PMID: 30685151
Objectives: The phosphodiesterase-5 inhibitor sildenafil was developed for the treatment of pulmonary hypertension. The authors investigated the efficacy and safety of sildenafil in the early postoperative period after mitral valve...
3.
Hazan O, Sternik L, Waiss D, Eldar M, Hoffer O, Goitein O, et al.
Comput Methods Biomech Biomed Engin . 2018 May; 21(4):370-378. PMID: 29722572
Invagination is an innovative technique for closing the left atrial appendage (LAA) to reduce the risk of thrombi formation. The influence of LAA invagination on the flow fields in the...
4.
Weisman D, Beinart R, Erez A, Koren-Morag N, Goldenberg I, Eldar M, et al.
J Interv Card Electrophysiol . 2017 Jul; 49(3):255-261. PMID: 28664342
Purpose: The aim of this study was to evaluate the effects of fish oils, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on ventricular tachyarrhythmic episodes (VTEs) in implantable cardioverter...
5.
Tofler G, Kopel E, Klempfner R, Eldar M, Buckley T, Goldenberg I
Am J Cardiol . 2017 Apr; 119(10):1560-1565. PMID: 28377021
Previous studies have shown that an acute coronary syndrome (ACS) may be triggered by external activities; however, their frequency, predictors, and significance are uncertain. We evaluated data from the National...
6.
Kurtzwald-Josefson E, Yadin D, Harun-Khun S, Waldman M, Aravot D, Shainberg A, et al.
Heart Rhythm . 2017 Mar; 14(7):1053-1060. PMID: 28336343
Background: The recessive form of catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2) is caused by mutations in cardiac calsequestrin (CASQ2), leading to protein deficiency. Objectives: The aims of this study were...
7.
Haron-Khun S, Weisbrod D, Bueno H, Yadin D, Behar J, Peretz A, et al.
EMBO Mol Med . 2017 Feb; 9(4):415-429. PMID: 28219898
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a stress-provoked ventricular arrhythmia, which also manifests sinoatrial node (SAN) dysfunction. We recently showed that SK4 calcium-activated potassium channels are important for automaticity of...
8.
Givon A, Vedernikova N, Luria D, Vatury O, Kuperstein R, Feinberg M, et al.
Isr Med Assoc J . 2016 Mar; 18(1):18-22. PMID: 26964274
Background: Transvenous lead extraction can lead to tricuspid valve damage. Objectives: To assess the incidence, risk factors and clinical outcome of tricuspid regurgitation (TR) following lead extraction. Methods: We prospectively...
9.
De Ferrari G, Dusi V, Spazzolini C, Bos J, Abrams D, Berul C, et al.
Circulation . 2016 Jan; 133(4):e366-7. PMID: 26811283
No abstract available.
10.
Ovadia-Blechman Z, Avrahami I, Weizman-Shammai E, Sharir T, Eldar M, Chouraqui P
Biomed Pharmacother . 2015 Sep; 74:83-8. PMID: 26349967
Background: Patients with coronary heart disease demonstrate changes in skin microcirculation and a decrease in cutaneous blood mass. Objective: The goal of this study was to assess the feasibility of...